The Pasteur Museum is housed in the apartment where Louis Pasteur spent his final seven years and offers a rare behind-the-scenes look at the living and working environment of the world-renowned scientist. Visitors can gain a unique insight into his everyday life alongside his ...
The Institut Pasteur’s scientific strategy focuses on developing original and innovative topics and promoting interdisciplinary and multidisciplinary cooperation and approaches. The Institut Pasteur teams have access to the technological resources ...
Ever since the introduction of the world’s first "Technical Microbiology" course in 1889, teaching has been a priority for the Institut Pasteur. The Institut Pasteur has an international reputation for quality teaching that attracts students from all over ...
The mission of the Industrial Partnership team is to detect, promote, assist and protect the inventive activities from research (inventions, know-how and biological materials) conducted at the Institut Pasteur (and in some Institutes of its international network), and transfer there to industrial ...
With international courses, PhD and postdoctoral traineeship, each institute of the Institut Pasteur International Network (RIIP) contributes to the transmission of knowledge with the training of young researchers all around the world. In this context, doctoral and postdoctoral programmes, study ...
Themis Bioscience’s Chikungunya Vaccine Study Results Published
Phase 1 trial of the vaccine candidate which was developed under an R&D collaboration between Themis Bioscience GmbH and the Institut Pasteur (Paris) shows good immunogenicity, safety and tolerability.
Moderna and Institut Pasteur Sign Strategic Research Collaboration
Moderna Therapeutics, a pioneer in the development of messenger RNA (mRNA) Therapeutics™ and the Institut Pasteur, today announced a long-term strategic research collaboration for the discovery and development of drugs and vaccines using Moderna’s mRNA Therapeutics™ platform. Valera, a Moderna venture company, will manage the research collaboration for Moderna.
Patronage: the Institut Pasteur and the Total Foundation renew their common commitment against infectious diseases
For 10 years, Total and its corporate foundation working alongside the Institut Pasteur and its International Network in the fight against infectious diseases. A new sponsorship agreement, of EUR 6 million for three years, was signed on 26 January 2015. It will provide funding, for public health and research projects in resource limited countries in order to better understand the therapeutic and vaccine responses in children.
Ebola: Study of the chains of transmission in Conakry
Researchers at the Institut Pasteur of Dakar and the Institut Pasteur in Paris have reconstructed chains of transmission of Ebola virus in the capital city of Guinea, from February to August 2014. The data show the positive impact of control measures on the evolution of the epidemic but highlight the challenges of Ebola control in large urban centres.
Since the beginning of the Ebola outbreak that is currently raging in Wet Africa, the Institut Pasteur, both in Paris and through its international network, has played an active role, applying its expertise to help contain the virus. Further information and all lastest news about the Institut Pasteur's involvement in the Ebola response can be found there.
Institut Pasteur is launching an International Call for Proposals for the creation of Pasteur International Joint Research Units within the Institut Pasteur International Network (RIIP), and within host institutions outside the RIIP.
Who can apply? Researchers from Institut Pasteur in Paris, researchers from the Institut Pasteur International Network or, from international research institutions in partnership with Institut Pasteur's teams.
Outside the Network the target countries for the first 2015 Call for Proposals are Brazil, India and Japan.
Segmented filamentous bacteria, partners in intestinal immunity, finally cultured in vitro
Despite the vital role of segmented filamentous bacteria in establishing gut immune homeostasis in vivo in mice, scientists, for the past 50 years, have been unable to reproduce this symbiosis in vitro to shed light on the cellular and molecular interactions involved. Now, scientists have successfully cultured and reproduced the complex life-cycle of these bacteria outside their host for the first time.
In a biological sense, what does it mean to be “in good health”? This far-reaching question is the focus of the “Laboratoire d'Excellence” project Milieu Intérieur (“Environment Within”). The Milieu Intérieur cohort is the first French cohort of its kind, comprised of a thousand healthy donors. Studying this cohort will help define the parameters of a healthy immune system. The recent analysis of the initial results generated from the cohort represents an important milestone for the scientists in this consortium.
Identification of an Achilles heel in the dengue virus gives new hope for vaccine development
Scientists have identified a vulnerable site on the surface of the dengue virus which is targeted by the only broadly neutralizing antibodies identified to date. This discovery offers a new target for the development of a vaccine to combat all four types of dengue virus currently in circulation.
Resident and recruited macrophages orchestrate the liver's defense against infection
Scientists have demonstrated that liver-resident macrophages are rapidly killed by the pathogenic bacterium Listeria monocytogenes. This early death triggers the recruitment of macrophages from the bloodstream to the liver. These macrophages start by bringing the bacterial infection under control; then, in an unexpected development, they actually replace the liver-resident macrophages that have been killed by the infection.